Scalper1 News
The artificial heart valve battle remains a bit of a draw. Medtronic (MDT) and Edwards Lifesciences (EW) offered competing sets of data on their artificial heart valves at the American College of Cardiology meeting in Washington, D.C., last weekend. On Wednesday, RBC Capital Markets analyst Glenn Novarro hiked his price target on Medtronic stock to 61 from 56, but shares already trade above his new price. Medtronic was up nearly 1% in midday Scalper1 News
Scalper1 News